Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
Abstract Background Equitable access to essential medicines of maintained efficacy, safety, quality, and cost-effectiveness must be ensured by a well-functioning health system. This study aims to identify the determinants of patients’ access to medicines at the primary health care (PHC) level from t...
Main Authors: | Hoda Ibrahim Rizk, Monira Mahmoud Elkholy, Abeer Abdou Barakat, Raghda Mostafa Mostafa Elsayed, Shaimaa A. M. Abd El Fatah |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-01-01
|
Series: | Journal of the Egyptian Public Health Association |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42506-020-00062-x |
Similar Items
-
Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
by: Alireza Olyaaeemanesh, et al.
Published: (2021-12-01) -
Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
by: Taryn Vian, et al.
Published: (2017-12-01) -
Pharmaceutical market access in emerging markets: concepts, components, and future
by: Anuj Kumar, et al.
Published: (2014-12-01) -
Stakeholders’ Perspectives Regarding Supply Chain System of Pharmaceuticals and Vaccines in Pakistan: A Qualitative Study
by: Madeeha Malik, et al.
Published: (2022-09-01) -
Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
by: Patrick McMullan, et al.
Published: (2018-01-01)